Search Results 1481-1490 of 14847 for anti-TNF drugs

1. Triamcinolone (Nasal Route) Before Using - Mayo Clinic

   Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

2. Lidocaine And Tetracaine (Topical Application Route) Side Effects - Mayo Clinic

   Side Effects. Drug information provided by: Merative, Micromedex®. Along with its needed effects, a medicine may cause some unwanted effects. Although not ...

3. Study of Dexamethasone Plus IXAZOMIB or Physician's Choice of Treatment in Relapsed or Refractory Systemic Light Chain (AL) Amyloidosis - Mayo Clinic

   Treatment options will include: dexamethasone alone, dexamethasone plus an alkylating agent (melphalan or cyclophosphamide), or dexamethasone plus an ...

4. Mayo Clinic Comprehensive Cancer Center — Research

   ... anti-cancer drugs in patients with advanced solid tumors and gliomas. The study is divided into two parts: single agent FT-2102 followed by combination therapy.

5. Streptozocin (Intravenous Route) Description and Brand Names - Mayo Clinic

   Streptozocin belongs to the group of medicines known as alkylating agents. It is used to treat cancer of the pancreas.

6. Fosinopril And Hydrochlorothiazide (Oral Route) Side Effects - Mayo Clinic

   Side Effects. Drug information provided by: Merative, Micromedex®. Along with its needed effects, a medicine may cause some unwanted effects. Although not ...

7. Radiation Therapy with or without Cetuximab in Treating Patients Who Have Undergone Surgery for Locally Advanced Head and Neck Cancer - Mayo Clinic

   Drugs & Supplements A-Z · Health Books · Healthy Living Program · Mayo Clinic ... Prior chemotherapy or anti-EGF therapy for a different cancer allowed. No ...

8. Desirudin (Subcutaneous Route) Before Using - Mayo Clinic

   Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

9. New oral anticoagulant drugs associated with lower kidney risks, Mayo Clinic research shows

   ROCHESTER, Minn. — Mayo Clinic researchers have shown a link between which type of oral anticoagulant (blood-thinning medication) a patient takes to prevent ...

10. Next-Generation TOP1 Inhibition To Treat Ovarian Cancer - Mayo Clinic Comprehensive Cancer Center Research

    This anti-cancer activity can be enhanced by adding DNA repair modulating agents, such as PARP inhibitors and ATR inhibitors. Our researchers are conducting ...